ExpressCells

ExpressCells uses genetic engineering to create custom cell lines for biological research

ExpressCells Co-founder Publishes New Data Derived from Cells Gene-Edited with FAST-HDR | ExpressCells 02/15/2023

ExpressCells' founder, Oscar Perez-Leal, has published a new case study of our gene-edited cell lines in Biomolecules. Check it out: https://bit.ly/ExpressCells-Biomolecules-Article

ExpressCells Co-founder Publishes New Data Derived from Cells Gene-Edited with FAST-HDR | ExpressCells The laboratory of Oscar Perez Leal, MD, co-founder of ExpressCells and Assistant Professor at Temple University, published data derived from cells created with FAST-HDR gene editing system. This illustrates a practical use of cells available from ExpressCells. PHILADELPHIA - Feb. 13, 2023 - PRLog --...

Wishing our clients, colleagues and friends a wonderful holiday season! | ExpressCells 12/23/2022

Wishing our clients, colleagues and friends a wonderful holiday season! | ExpressCells Wishing our clients, colleagues and friends a wonderful holiday season! — ExpressCells. Cell line gene editing; Cell line development; CRISPR DNA editing, CRISPR gene editing technology; Knock-in; Cell line service. by ExpressCells | Dec 23, 2022 | Company news Better Knock-ins, Better Cell Lines,...

Did you miss the ExpressCells webinar on gene-editing? No problem! Watch it on-demand at xpresscells.com. | ExpressCells 12/09/2022

Did you miss the ExpressCells webinar on gene-editing? No problem! Watch it on-demand at xpresscells.com.

Did you miss the ExpressCells webinar on gene-editing? No problem! Watch it on-demand at xpresscells.com. | ExpressCells Creating Better Gene-Edited Cell Lines with the FAST-HDR System What You’ll Learn: Understand the current challenges in creating custom gene-edited cell lines Know the technology underlying the FAST-HDR gene-editing system, including its use with CRISPR Be able to describe the advantages of the FA...

Creating Better Gene-Edited Cell Lines with the FAST-HDR System 11/01/2022

Did you miss the ExpressCells webinar on gene-editing last week? No problem! Watch it on-demand at

Creating Better Gene-Edited Cell Lines with the FAST-HDR System Cell lines are the core of biological research. Scientists need cell lines for drug development, basic biology research, safety testing, and biologic therapeutic production. Since the 1980s, genetic manipulation has allowed researchers to tailor cell lines to the experiment or production purpose. Ov...

Be sure to join ExpressCells at the upcoming live webinar event, Creating Better Gene-Edited Cell Lines, Wednesday, October 26, 2022, 11:00 AM ET | ExpressCells 10/04/2022

Cell lines are the core of biological research. Scientists need cell lines for drug development, basic biology research, safety testing, and biologic therapeutic production. This webinar will discuss the basis of the FAST-HDR technology and illustrate several uses. The first part is a presentation by Oscar Perez-Leal, MD, the inventor of the technology. Oscar will […]

Be sure to join ExpressCells at the upcoming live webinar event, Creating Better Gene-Edited Cell Lines, Wednesday, October 26, 2022, 11:00 AM ET | ExpressCells Cell lines are the core of biological research. Scientists need cell lines for drug development, basic biology research, safety testing, and biologic therapeutic production. This webinar will discuss the basis of the FAST-HDR technology and illustrate several uses. The first part is a presentation b...

No scientist wants to wait to start an experiment. ExpressCells gets it–we were founded by scientists. | ExpressCells 08/01/2022

No scientist wants to wait to start an experiment. ExpressCells gets it–we were founded by scientists. That’s why we developed the patented FAST-HDR gene-editing system. Want a single knock-in? In many cases, we can send you a cell pool in about 60 days. Give us a little more time and we can deliver a clonal selection and/or a cell with multiple knock-ins. We also do knock-outs and point mutations. Now you […]

No scientist wants to wait to start an experiment. ExpressCells gets it–we were founded by scientists. | ExpressCells That’s why we developed the patented FAST-HDR gene-editing system. Want a single knock-in? In many cases, we can send you a cell pool in about 60 days. Give us a little more time and we can deliver a clonal selection and/or a cell with multiple knock-ins. We also do knock-outs and point mutations....

How good is the ExpressCells team? So good that CIC is featuring Shamim Naghdi PhD, our amazing Scientific Director, in their new ad campaign! | ExpressCells 06/29/2022

Shamim Naghdi, Scientific Director at ExpressCells, shares her story in CIC’s latest campaign. Learn More About CIC

How good is the ExpressCells team? So good that CIC is featuring Shamim Naghdi PhD, our amazing Scientific Director, in their new ad campaign! | ExpressCells Shamim Naghdi, Scientific Director at ExpressCells, shares her story in CIC's latest campaign. See Story Learn More About CIC Visit CIC

Virtual Rocket Pitch + Power Networking by CONNECTpreneur Investor Network 06/22/2022

We're presenting to Investors at CONNECTpreneur next week. Hope you can join us! https://www.facebook.com/Connectpreneur/posts/pfbid0HHXTVPxsncDy5ZyYv6hyUEwaci5Ap7cyiBmbHLFPZP6F7BTfayEotVHUroAbofdal

Virtual Rocket Pitch + Power Networking by CONNECTpreneur Investor Network CONNECTpreneur's Virtual Rocket Pitch - The world's largest investor pitch events. Come learn, connect with others, and be inspired

Join the ExpressCells team! We’re looking for a Senior Genetic Engineering Scientist #opportunity #geneediting | ExpressCells 03/08/2022

Join the ExpressCells team! We’re looking for a Senior Genetic Engineering Scientist

Join the ExpressCells team! We’re looking for a Senior Genetic Engineering Scientist #opportunity #geneediting | ExpressCells Join our Team!

This is your chance to show your support for ExpressCells. We are one of 16 companies in the 2022 PHL INNO Madness Bracket. | ExpressCells 03/02/2022

We’re a #4 seed 2022 PHL INNO Madness, but want to show we can win it all. Vote for ExpressCells in round one of the tournament! Voting ends at 11:59pm on March 7th

This is your chance to show your support for ExpressCells. We are one of 16 companies in the 2022 PHL INNO Madness Bracket. | ExpressCells We're a #4 seed, but want to show we can win it all. Vote for ExpressCells in round one of the tournament! Voting ends at 11:59pm on March 7th VOTE NOW

02/17/2022

ExpressCells is hiring! Know a great genetic engineering scientist? Please share this opening with them.

ExpressCells congratulates our Co-Founder, Oscar Perez Leal and his colleagues for the first publication featuring ExpressCells’ FAST-HDR gene editing system. Learn more about how FAST-HDR can help your cell-based research at xpresscells.com. |... 01/04/2022

ExpressCells congratulates our Co-Founder, Oscar Perez-Leal and his colleagues for the first publication featuring ExpressCells' FAST-HDR gene editing system. Learn more about how FAST-HDR can help your cell-based research at https://xpresscells.com/

ExpressCells congratulates our Co-Founder, Oscar Perez Leal and his colleagues for the first publication featuring ExpressCells’ FAST-HDR gene editing system. Learn more about how FAST-HDR can help your cell-based research at xpresscells.com. |... "We believe the FAST-HDR system is a versatile methodology for developing endogenous tagging with CRISPR according to the needs of the researcher, as it works on any cell line, facilitates multiplexing, and allows the use of any protein tag." Download Full Press Release Read the Article from The CRI...

ExpressCells and Funakoshi Establish Japanese Distribution Agreement. Partnership will Introduce ExpressCells’ Genetically-Edited Cell Lines to Japan | ExpressCells 12/20/2021

ExpressCells, Inc., and Funakoshi Co., Ltd., a leading Japanese distributor of scientific products, announced today that the companies have entered into a strategic partnership where Funakoshi will distribute ExpressCells’ products in Japan. “We are honored that Funakoshi, a highly-respected company with a long history of extending the frontiers in life science, will distribute our catalog […]

ExpressCells and Funakoshi Establish Japanese Distribution Agreement. Partnership will Introduce ExpressCells’ Genetically-Edited Cell Lines to Japan | ExpressCells ExpressCells, Inc., and Funakoshi Co., Ltd., a leading Japanese distributor of scientific products, announced today that the companies have entered into a strategic partnership where Funakoshi will distribute ExpressCells' products in Japan. "We are honored that Funakoshi, a highly-respected company...

Want your business to be the top-listed Engineering Company in Philadelphia?
Click here to claim your Sponsored Listing.

Category

Address


3675 Market Street , Suite 200
Philadelphia, PA
19104

Other Biotechnology in Philadelphia (show all)
OX OX
Oxford Street
Philadelphia

a warehouse with fun.

Pera Labs Pera Labs
3675 Market Street Suite 200
Philadelphia, 19104

We are developing next gen solutions for animal and human reproductive health.

Carisma Therapeutics Carisma Therapeutics
Philadelphia, 19104

HelaPlex HelaPlex
Philadelphia

Commercial Co-Working for Life Science Start-Ups & Virtual Biotech Companies. Qualified Tenant Typ

Gnosko Bio Gnosko Bio
Philadelphia, 19146

Gnosko accelerates scientific progress and delivers value by ensuring the best products, service, a

Passage Bio Passage Bio
1 Commerce Square, 39th Floor
Philadelphia, 19103

ViaClean Technologies ViaClean Technologies
230 S. Broad Street, Suite 1201
Philadelphia, 19102

ViaClean Technologies focuses on advanced antimicrobial surface protection solutions

Biomeme, Inc. Biomeme, Inc.
401 N Broad Street Suite 222
Philadelphia, 19108

Biomeme's platform transforms your smartphone into a mobile lab for advanced DNA diagnostics and real-time disease surveillance.

Biomaterix Biomaterix
Philadelphia

Cell Eleven Cell Eleven
Philadelphia, 19100

Cell Eleven is a DIY biotech tool company focusing on modularity, cost, and accessibility.

Century Therapeutics Century Therapeutics
3675 Market Street
Philadelphia, 19104

Century Therapeutics is developing novel allogeneic living drugs for oncology that overcome the limi

Protalex, Inc. Protalex, Inc.
Philadelphia

Protalex, Inc. (OTCQB: PRTX) is focused on the development of a class of drugs for treating a wide a